Status Epilepticus
"Status Epilepticus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30)
Descriptor ID |
D013226
|
MeSH Number(s) |
C10.597.742.785 C23.888.592.742.785
|
Concept/Terms |
Status Epilepticus- Status Epilepticus
- Status Epilepticus, Generalized
- Generalized Status Epilepticus
Grand Mal Status Epilepticus- Grand Mal Status Epilepticus
- Status Epilepticus, Grand Mal
- Status Epilepticus, Generalized Convulsive
- Generalized Convulsive Status Epilepticus
Non-Convulsive Status Epilepticus- Non-Convulsive Status Epilepticus
- Non Convulsive Status Epilepticus
- Status Epilepticus, Non-Convulsive
- Status Epilepticus, Non Convulsive
Status Epilepticus, Subclinical- Status Epilepticus, Subclinical
- Subclinical Status Epilepticus
- Status Epilepticus, Electrographic
- Electrographic Status Epilepticus
|
Below are MeSH descriptors whose meaning is more general than "Status Epilepticus".
Below are MeSH descriptors whose meaning is more specific than "Status Epilepticus".
This graph shows the total number of publications written about "Status Epilepticus" by people in this website by year, and whether "Status Epilepticus" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 0 | 1 | 2009 | 0 | 1 | 1 | 2011 | 1 | 0 | 1 | 2012 | 2 | 0 | 2 | 2014 | 2 | 1 | 3 | 2015 | 0 | 1 | 1 | 2017 | 2 | 0 | 2 | 2018 | 1 | 0 | 1 | 2019 | 0 | 1 | 1 | 2020 | 4 | 0 | 4 | 2021 | 1 | 1 | 2 | 2022 | 3 | 0 | 3 | 2023 | 3 | 0 | 3 | 2024 | 6 | 0 | 6 | 2025 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Status Epilepticus" by people in Profiles.
-
Espino PH, Eschbach K, Blank LJ, Cervenka MC, Muscal E, Farias-Moeller R, Gilmore EJ, Gopaul MT, Haider HA, Hanin A, Hirsch LJ, Kellogg MA, Kluger G, Lee ST, Melendez-Zaidi AE, Navarro V, Oliger AC, Pasini E, Reuner G, Sharpe CM, Sheikh ZB, Steigleder L, Steriade C, Stredny CM, Strzelczyk A, Taraschenko O, van Baalen A, Vinette SA, Wickstr?m R, Wong NW, Yoo J, Gofton TE. New onset refractory status epilepticus: Long-term outcomes beyond seizures. Epilepsia. 2025 Apr; 66(4):988-1005.
-
Kazazian K, Gaspard N, Hirsch LJ, Kellogg M, Hocker SE, Wong N, Farias-Moeller R, Eschbach K, Gofton TE. Age-associated differences in FIRES: Characterizing prodromal presentation and long-term outcomes via the web-based NORSE/FIRES Family Registry. Epilepsia. 2025 Mar; 66(3):e35-e40.
-
Eschbach K, Reedy J, Gofton T, Gopaul M, Farias-Moeller R, Kellogg M, Knupp K, Hirsch LJ, Wong N, Dorsey Holliman B. Navigating life after New-onset refractory status epilepticus (NORSE) and Febrile infection-related epilepsy syndrome (FIRES): Insights from caregiver and patient interviews. Epilepsy Behav. 2025 Feb; 163:110236.
-
Kazazian K, Gaspard N, Hirsch LJ, Kellogg M, Hocker SE, Wong N, Farias-Moeller R, Eschbach K, Gofton TE. Communication trends over time in new-onset refractory status epilepticus (NORSE): Interim analysis from the NORSE/FIRES Family Registry. Epilepsy Behav. 2024 Nov; 160:110023.
-
Hanin A, Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel CM, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Wainwright MS, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ. Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis. Epilepsia. 2024 Aug; 65(8):e148-e155.
-
Liang LP, Sri Hari A, Day BJ, Patel M. Pharmacological elevation of glutathione inhibits status epilepticus-induced neuroinflammation and oxidative injury. Redox Biol. 2024 07; 73:103168.
-
Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel C, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ, Hanin A. Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis. Epilepsia. 2024 Jun; 65(6):e87-e96.
-
Hanin A, Eschbach K, Gofton TE, Gopaul M, Howe CL, Lai YC, Koh S, Shen H, Hirsch LJ. New onset refractory status epilepticus: Summary of the NORSE Institute roundtable during the 2023 American Epilepsy Society meeting, Orlando, Florida. Epilepsia. 2024 Apr; 65(4):1145-1146.
-
Nurre ER, Shah A, Hansen CJ, Dowling C, Thakolwiboon S, Mao-Draayer Y, Mihaylova TG. Multiple sclerosis and seizures: A retrospective observational study in a multiple sclerosis autoimmunity center of excellence. Seizure. 2024 Feb; 115:44-49.
-
Daniels C, Greene C, Smith L, Pestana-Knight E, Demarest S, Zhang B, Benke TA, Poduri A, Olson HE. CDKL5 deficiency disorder and other infantile-onset genetic epilepsies. Dev Med Child Neurol. 2024 Apr; 66(4):456-468.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|